Reports
Sale
Global Coagulation Analyzer Market Size, Trends, Growth: By Product Type: Instruments/Analyzers, Reagents, Consumables, Others; By Testing Type: Prothrombin Time Testing (PT), Fibrinogen Testing (FT), Others; By Technology Type; By End User; Regional Analysis; Market Dynamics; Supplier Landscape; 2024-2032
Global Coagulation Analyzer Market Size
The global coagulation analyzer market was valued at USD 4.5 billion in 2023, driven by increasing incidence of blood disorders across the globe. The market is expected to grow at a CAGR of 6.29% during the forecast period of 2024-2032, with the values likely to reach USD 7.8 billion by 2032.
Global Coagulation Analyzer Market Outlook
- The demand for coagulation analyzer is on the rise, intended to combat the blood disorders. There is approximately 100,000 blood clot-related deaths annually.
- One of the major market trends includes rising mergers between key companies to provide optimized imaging solutions for patients.
- North America region is expected to experience substantial growth in the forecast period.
Global Coagulation Analyzer Market Overview
Coagulation analyzer is a device that measures and evaluates the coagulation system of the blood and access the risk of clotting or bleeding. It helps to avoid the risk of embolism, heart attack, hemophilia, and thrombosis by detecting the presence of clots in the blood vessels. Nearly 900,000 people are affected by blood clots annually. There are various types of coagulation analyzers in the market. To name a few, there are automated coagulation analyzers and semi-automated coagulation analyzers.
Global Coagulation Analyzer Market Growth Drivers
Surge in Product Launches to have a Significant Impact on the Market Landscape
With rising incidence of coagulation disorders, the market has been witnessing an influx of analyzers to provide enhanced patient outcomes. In February 2023, Siemens Healthineers and diagnostic services firm Unilabs formed a multi-year strategic agreement valued at more than EUR 200 million. Through this agreement, Siemens Healthineers committed to install high- and mid-volume immunoassay, clinical chemistry analyzers, sample handlers, hemostasis analyzers, and automation solutions. While Unilabs acquired more than 400 laboratory analyzers to improve its laboratory infrastructure and enhance its laboratory operations and throughput.
Growth in Strategic Partnerships and Mergers to Meet Rising Coagulation Analyzer Market Demand
In February 2023, Siemens Healthineers signed a global (Original Equipment Manufacturers) OEM agreement on hemostasis products with Sysmex Corporation. Under this, the company aimed at supplying their products in the diagnostic field of hemostasis on an OEM basis. The organizations offered products used in testing for blood clotting disorders, preoperative bleeding risk management, and the monitoring of patients receiving anticoagulant therapy medications. This represents a significant partnership in the medical diagnostics industry.
Global Coagulation Analyzer Market Trends
The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:
| Key Trends | Impact |
| Advancements in Diagnostic Technology | The automated coagulation analyzers incorporates both artificial intelligence (AI) and machine learning (ML) to enhance their diagnostics capabilities. Automation allows for conducting more tests in less time with less manual intervention. AI and ML enhances the device’s ability to infer complex database. The algorithms can assist in analyzing historical data to predict patient trends, along with this it can also provide insights on chronic disease management. |
| Increasing Prevalence of Blood Disorders | The blood disorders like thrombophilia, hemophilia, deep vein thrombosis is increasing in geriatric population, which increases the demand for coagulation tests. Blood disorders require regular monitoring to manage treatment, and coagulation analyzers play an important role in performing these tests. |
| Point-of-care Testing | The popularity of point-of-care setting is increasing as it offers rapid results and convenience. Modern point-of-care coagulation analyzers are user friendly and required minimum training. Due to its lightweight design and compactness, it is portable and can be used in different settings like home care and mobile clinics. |
| Expansion in Emerging Economies | Investments in healthcare development and upgradation of healthcare facilities includes coagulation analyzers. Increasing public and private investments with expansion of health insurance allows patients to access healthcare facilities. Growing public awareness about advanced diagnostic techniques increases knowledge and offers importance of diagnosis in disease management. Therefore, with awareness, the demand for diagnostic services increases. |
Global Coagulation Analyzer Market Segmentation
Market Breakup by Product Type
- Instruments/Analyzers
- Reagents
- Consumables
- Others
Market Breakup by Testing Type
- Prothrombin Time Testing (PT)
- Fibrinogen Testing (FT)
- Activated Partial Thromboplastin Time Testing (APTT)
- Activated Clotting Time Testing (ACT)
- D-Dimer Testing
- Platelet Function Testing
- Anti-Factor Xa Testing
- Heparin & Protamine Dose-response Test for ACT
- Others
Market Breakup by Technology Type
- Optical Technology
- Mechanical Technology
- Electrochemical Technology
- Others
Market Breakup by End User
- Clinical Laboratories
- Diagnostic Centers
- Hospitals
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Coagulation Analyzer Market Share
Market Segmentation Based on Product Type is Projected to Witness Significant Growth
Based on product type, the market segmentation includes instruments/analyzers, reagents, consumables among others. The instruments/analyzers segment is estimated to witness significant growth, driven by its increasing role in diagnosis and monitoring of blood clotting disorders such as thrombosis and hemophilia. The growth is propelled by advancements in technologies that improves the efficiency and precision of these tests. The fastest growing segments is expected to be of consumables including sample collection tubes and test strips. This growth is attributed to the recurring and growing need for these products for testing procedures. These are disposable which offers control against cross-contamination. The products that ensure safety are easily adopted and contributes to the market value.
Optical Technology is Expected to Lead the Market Share Based on Technology Type
Based on technology, the market constitutes optical technology, mechanical technology, electrochemical technology, and others. The utilization of light absorption measurement to assess blood coagulation is done by optical technology, which is the largest segment. The wide application can also be attributed to its reliability, high accuracy, and extensive adoption in automated analyzers that are standard in many laboratories.
Mechanical technology is the traditional method, used for detection of clot through physical changes observed in the sample. The electrochemical technology is expected to experience fastest growth in this segment, owing to its importance in quick and accurate blood analysis in point-of-care settings. The growth is also driven by development of portable coagulation testing devices.
Global Coagulation Analyzer Market Analysis by Region
Regionally, the market report offers an insight into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America region is propelled by the advanced healthcare infrastructure, presence of leading market players, and high healthcare expenditure. The attention to research and development along with its quick adoption of latest technologies drives the market towards the leading position.
Asia Pacific is poised to witness significant growth in the forecast period. Increased awareness about healthcare, significant budget allocation for improving the healthcare infrastructure, predominantly in countries like India and China is projected to boost the market value.
Leading Players in the Global Coagulation Analyzer Market
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Abbott Laboratories
- Danaher Corporation
- Siemens Healthineers Company
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
- HORIBA, Ltd
- Nihon Kohden Corporation
- F. Hoffmann-La Roche Ltd.
- Maccura Biotechnology Co. Ltd.
- Bio Group Medical System
- Genrui Biotech Co., Ltd
- A&T Corporation
- Beijing Succeeder Technology Inc.
- Diagnostica Stago
- Helena Laboratories Corporation
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Testing Type |
|
| Breakup by Technology Type |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Key Questions Answered in the Global Coagulation Analyzer Market Report
- What was the global coagulation analyzer market value in 2023?
- What is the global coagulation analyzer market forecast outlook for 2024-2032?
- What are the regional markets covered in the EMR report?
- What is market segmentation based on product type?
- What is the market breakup based on test types?
- Who are the major end users in the market?
- What type of technologies are present in the market?
- What are the major factors aiding the global coagulation analyzer market demand?
- How has the coagulation analyzer market performed so far and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- Which regional market is expected to lead the market share in the forecast period?
- Which country is expected to experience expedited growth during the forecast period?
- How does the prevalence and incidence of blood disorders affect the market landscape?
- What are the major global coagulation analyzer market trends?
- How does the rise in the geriatric population impact the market size?
- What product type will dominate the market share?
- Which technology type will experience the highest demand in the market segment?
- Who are the key players involved in the coagulation analyzer market?
- What is patent landscape of the market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, and mergers & acquisitions among the key market players shaping the market dynamics?
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Coagulation Analyzer Market Overview
3.1 Global Coagulation Analyzer Market Historical Value (2017-2023)
3.2 Global Coagulation Analyzer Market Forecast Value (2024-2032)
4 Global Coagulation Analyzer Market Landscape*
4.1 Global Coagulation Analyzer: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Coagulation Analyzer: Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Testing Type
5 Global Coagulation Analyzer Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Coagulation Analyzer Market Segmentation (2017-2032)
6.1 Global Coagulation Analyzer Market (2017-2032) by Product Type
6.1.1 Market Overview
6.1.2 Instruments/Analyzers
6.1.3 Reagents
6.1.4 Consumables
6.1.5 Others
6.2 Global Coagulation Analyzer Market (2017-2032) by Testing Type
6.2.1 Market Overview
6.2.2 Prothrombin Time Testing (PT)
6.2.3 Fibrinogen Testing (FT)
6.2.4 Activated Partial Thromboplastin Time Testing (APTT)
6.2.5 Activated Clotting Time Testing (ACT)
6.2.6 D-Dimer Testing
6.2.7 Platelet Function Testing
6.2.8 Anti-Factor Xa Testing
6.2.9 Heparin & Protamine Dose-response Test for ACT
6.2.10 Others
6.3 Global Coagulation Analyzer Market (2017-2032) by Technology Type
6.3.1 Market Overview
6.3.2 Optical Technology
6.3.3 Mechanical Technology
6.3.4 Electrochemical Technology
6.3.5 Others
6.4 Global Coagulation Analyzer Market (2017-2032) by End User
6.4.1 Market Overview
6.4.2 Clinical Laboratories
6.4.3 Diagnostic Centers
6.4.4 Hospitals
6.4.5 Others
6.5 Global Coagulation Analyzer Market (2017-2032) by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Coagulation Analyzer Market (2017-2032)
7.1 North America Coagulation Analyzer Market (2017-2032) by Product Type
7.1.1 Market Overview
7.1.2 Instruments/Analyzers
7.1.3 Reagents
7.1.4 Consumables
7.1.5 Others
7.2 North America Coagulation Analyzer Market (2017-2032) by Testing Type
7.2.1 Market Overview
7.2.2 Prothrombin Time Testing (PT)
7.2.3 Fibrinogen Testing (FT)
7.2.4 Activated Partial Thromboplastin Time Testing (APTT)
7.2.5 Activated Clotting Time Testing (ACT)
7.2.6 D-Dimer Testing
7.2.7 Platelet Function Testing
7.2.8 Anti-Factor Xa Testing
7.2.9 Heparin & Protamine Dose-response Test for ACT
7.2.10 Others
7.3 North America Coagulation Analyzer Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Coagulation Analyzer Market (2017-2032)
8.1 Europe Coagulation Analyzer Market (2017-2032) by Product Type
8.1.1 Market Overview
8.1.2 Instruments/Analyzers
8.1.3 Reagents
8.1.4 Consumables
8.1.5 Others
8.2 Europe Coagulation Analyzer Market (2017-2032) by Testing Type
8.2.1 Market Overview
8.2.2 Prothrombin Time Testing (PT)
8.2.3 Fibrinogen Testing (FT)
8.2.4 Activated Partial Thromboplastin Time Testing (APTT)
8.2.5 Activated Clotting Time Testing (ACT)
8.2.6 D-Dimer Testing
8.2.7 Platelet Function Testing
8.2.8 Anti-Factor Xa Testing
8.2.9 Heparin & Protamine Dose-response Test for ACT
8.2.10 Others
8.3 Europe Coagulation Analyzer Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Coagulation Analyzer Market (2017-2032)
9.1 Asia Pacific Coagulation Analyzer Market (2017-2032) by Product Type
9.1.1 Market Overview
9.1.2 Instruments/Analyzers
9.1.3 Reagents
9.1.4 Consumables
9.1.5 Others
9.2 Asia Pacific Coagulation Analyzer Market (2017-2032) by Testing Type
9.2.1 Market Overview
9.2.2 Prothrombin Time Testing (PT)
9.2.3 Fibrinogen Testing (FT)
9.2.4 Activated Partial Thromboplastin Time Testing (APTT)
9.2.5 Activated Clotting Time Testing (ACT)
9.2.6 D-Dimer Testing
9.2.7 Platelet Function Testing
9.2.8 Anti-Factor Xa Testing
9.2.9 Heparin & Protamine Dose-response Test for ACT
9.2.10 Others
9.3 Asia Pacific Coagulation Analyzer Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 ASEAN
9.3.5 Australia
9.3.6 Others
10 Latin America Coagulation Analyzer Market (2017-2032)
10.1 Latin America Coagulation Analyzer Market (2017-2032) by Product Type
10.1.1 Market Overview
10.1.2 Instruments/Analyzers
10.1.3 Reagents
10.1.4 Consumables
10.1.5 Others
10.2 Latin America Coagulation Analyzer Market (2017-2032) by Testing Type
10.2.1 Market Overview
10.2.2 Prothrombin Time Testing (PT)
10.2.3 Fibrinogen Testing (FT)
10.2.4 Activated Partial Thromboplastin Time Testing (APTT)
10.2.5 Activated Clotting Time Testing (ACT)
10.2.6 D-Dimer Testing
10.2.7 Platelet Function Testing
10.2.8 Anti-Factor Xa Testing
10.2.9 Heparin & Protamine Dose-response Test for ACT
10.2.10 Others
10.3 Latin America Coagulation Analyzer Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Coagulation Analyzer Market (2017-2032)
11.1 Middle East and Africa Coagulation Analyzer Market (2017-2032) by Product Type
11.1.1 Market Overview
11.1.2 Instruments/Analyzers
11.1.3 Reagents
11.1.4 Consumables
11.1.5 Others
11.2 Middle East and Africa Coagulation Analyzer Market (2017-2032) by Testing Type
11.2.1 Market Overview
11.2.2 Prothrombin Time Testing (PT)
11.2.3 Fibrinogen Testing (FT)
11.2.4 Activated Partial Thromboplastin Time Testing (APTT)
11.2.5 Activated Clotting Time Testing (ACT)
11.2.6 D-Dimer Testing
11.2.7 Platelet Function Testing
11.2.8 Anti-Factor Xa Testing
11.2.9 Heparin & Protamine Dose-response Test for ACT
11.2.10 Others
11.3 Middle East and Africa Coagulation Analyzer Market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication Year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Market Share by Top 5 Companies
17.2 Abbott Laboratories
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Danaher Corporation
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Siemens Healthineers Company
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Sysmex Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Thermo Fisher Scientific Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 HORIBA, Ltd
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Nihon Kohden Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 F. Hoffmann-La Roche Ltd.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Maccura Biotechnology Co. Ltd.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Bio Group Medical System
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Genrui Biotech Co., Ltd
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 A&T Corporation
17.13.1 Financial Analysis
17.13.2 Product Mergers and Acquisitions
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Beijing Succeeder Technology Inc.
17.14.1 Financial Analysis
17.14.2 Product Mergers and Acquisitions
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Diagnostica Stago
17.15.1 Financial Analysis
17.15.2 Product Mergers and Acquisitions
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 Helena Laboratories Corporation
17.16.1 Financial Analysis
17.16.2 Product Mergers and Acquisitions
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
18 Global Coagulation Analyzer Market – Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER